The Federal 340B Drug Pricing Program has grown from a modest drug discount program into […]
#76 What’s Ahead in Pharmaceutical Antitrust Enforcement? Taking Stock of Key Pharmaceutical Issues and Enforcement Actions
Posted 6 years ago Tagged antitrust biologics daraprim patent wars pay-for-delay pharmaceutical antitrust pharmaceuticals
Although there is little question as to the need for affordable, accessible, and high-quality pharmaceuticals, […]
